FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.6  |  FHIR Version n/a  User: [n/a]

787994008: Antibacterial therapeutic role (role)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2020. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3778326014 Antibacterial therapeutic role (role) en Fully specified name Active Entire term case insensitive SNOMED CT core module
3778327017 Antibacterial therapeutic role en Synonym Active Entire term case insensitive SNOMED CT core module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Antibacterial therapeutic role Is a Therapeutic role false Inferred relationship Existential restriction modifier
Antibacterial therapeutic role Is a Antiinfective therapeutic role true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Oritavancin Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only ornidazole (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only oxacillin (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clarithromycin 1 gram/1 each prolonged-release oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely dirithromycin 250 milligram/1 each gastro-resistant oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 3 milligram/1 milliliter and dexamethasone 1 milligram/1 milliliter conventional release ear suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely azithromycin (as azithromycin dihydrate) 500 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefalexin 500 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefalexin (as cefalexin monohydrate) 250 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefalexin (as cefalexin monohydrate) 250 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefalexin (as cefalexin monohydrate) 500 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely pivmecillinam hydrochloride 200 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tetracycline (as tetracycline hydrochloride) 250 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tetracycline (as tetracycline hydrochloride) 250 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin (as amoxicillin trihydrate) 250 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin (as amoxicillin trihydrate) 500 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefaclor (as cefaclor monohydrate) 250 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefaclor (as cefaclor monohydrate) 500 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefadroxil (as cefadroxil monohydrate) 500 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefuroxime (as cefuroxime axetil) 125 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefuroxime (as cefuroxime axetil) 250 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 250 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 500 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ciprofloxacin (as ciprofloxacin hydrochloride) 750 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely minocycline (as minocycline hydrochloride) 100 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely minocycline (as minocycline hydrochloride) 100 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely minocycline (as minocycline hydrochloride) 50 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely minocycline (as minocycline hydrochloride) 50 milligram/1 each conventional release oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely flucloxacillin (as flucloxacillin sodium) 250 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely flucloxacillin (as flucloxacillin sodium) 500 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely levofloxacin (as levofloxacin hemihydrate) 250 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ampicillin (as ampicillin trihydrate) 250 milligram and flucloxacillin (as flucloxacillin sodium) 250 milligram/1 each conventional release oral capsule (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin (as amoxicillin trihydrate) 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin (as amoxicillin trihydrate) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely amoxicillin (as amoxicillin trihydrate) 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing prednisolone and sulfacetamide (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only prednisolone and sulfacetamide (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing prednisolone and sulfacetamide in ocular dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only prednisolone and sulfacetamide in ocular dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing fluorometholone and sulfacetamide (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only fluorometholone and sulfacetamide (medicinal product) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing fluorometholone and sulfacetamide in ocular dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing only fluorometholone and sulfacetamide in ocular dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely procaine benzylpenicillin 600000 unit/1 milliliter conventional release suspension for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely benzathine benzylpenicillin 150000 unit/1 milliliter and procaine benzylpenicillin 150000 unit/1 milliliter conventional release suspension for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely benzathine benzylpenicillin 900000 unit/1 milliliter and procaine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely colistin 1.5 million unit/1 each conventional release oral tablet (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely benzathine benzylpenicillin 300000 unit/1 milliliter conventional release suspension for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely benzathine benzylpenicillin 600000 unit/1 milliliter conventional release suspension for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sulfacetamide sodium 100 milligram/1 gram conventional release eye ointment (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sulfacetamide sodium 25 milligram/1 gram conventional release eye ointment (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sulfacetamide sodium 200 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sulfacetamide sodium 300 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sulfacetamide sodium 60 milligram/1 gram conventional release eye ointment (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely spectinomycin hydrochloride 400 milligram/1 milliliter conventional release suspension for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely metronidazole 500 milligram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely erythromycin 250 milligram/1 each conventional release oral capsule (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 40 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely erythromycin (as erythromycin ethylsuccinate) 80 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefotaxime (as cefotaxime sodium) 20 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely chloramphenicol (as chloramphenicol sodium succinate) 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clindamycin (as clindamycin hydrochloride) 75 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tetracycline 25 milligram/1 milliliter conventional release oral solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tetracycline 10 milligram/1 gram conventional release cutaneous ointment (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tetracycline 10 milligram/1 milliliter conventional release cutaneous lotion (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ciprofloxacin 2 milligram/1 milliliter and hydrocortisone 10 milligram/1 milliliter conventional release ear suspension (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely sulfafurazole 100 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely bacampicillin 25 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely oxacillin 50 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely dicloxacillin 12.5 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely mafenide (as mafenide acetate) 85 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cloxacillin 25 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely chlortetracycline 30 milligram/1 gram conventional release cutaneous ointment (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release ear solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely hydrocortisone acetate 15 milligram/1 milliliter and neomycin (as neomycin sulfate) 5 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely tobramycin 60 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely fluorometholone acetate 1 milligram/1 milliliter and tobramycin 3 milligram/1 milliliter conventional release eye suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clindamycin phosphate 10 milligram/1 milliliter conventional release cutaneous foam (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clindamycin phosphate 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely clindamycin phosphate 12 milligram/1 gram and tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely benzoyl peroxide 25 milligram/1 gram and clindamycin phosphate 12 milligram/1 gram conventional release cutaneous gel (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely linezolid 20 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely gentamicin (as gentamicin sulfate) 900 microgram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely gentamicin (as gentamicin sulfate) 1 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely gentamicin (as gentamicin sulfate) 1 milligram/1 gram conventional release cutaneous ointment (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely gentamicin (as gentamicin sulfate) 3 milligram/1 gram conventional release eye ointment (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely gentamicin (as gentamicin sulfate) 10 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely aztreonam 75 milligram/1 milliliter conventional release solution for inhalation (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely mupirocin (as mupirocin calcium) 20 milligram/1 milliliter conventional release cutaneous cream (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely azithromycin 33.3 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefpodoxime 10 milligram/1 milliliter conventional release oral suspension (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely lomefloxacin 3 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely ertapenem (as ertapenem sodium) 1 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely moxifloxacin (as moxifloxacin hydrochloride) 5 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefotaxime sodium 2 gram/1 vial powder for conventional release solution for injection (clinical drug) Plays role False Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefotaxime sodium 200 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely cefotaxime sodium 40 milligram/1 milliliter conventional release solution for injection (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing precisely phenoxymethylpenicillin potassium 3 milligram/1 milliliter conventional release eye solution (clinical drug) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier
Product containing sarecycline in oral dose form (medicinal product form) Plays role True Antibacterial therapeutic role Inferred relationship Existential restriction modifier

Start Previous Page 13 of 27 Next End

This concept is not in any reference sets

Back to Start